DiscoverSLAS Discovery Author InsightsHigh-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2
High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2

High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2

Update: 2020-11-18
Share

Description

SLAS Discovery 25.10 December 2020

Rob Howes discusses the paper "High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2" with authors Meredith Gardner (Scripps Research) and Michael Farzan (Scripps Research).

This research is part of the December Special Issue, Drug Discovery Targeting COVID-19 with Associate Editor Tim Spicer.

Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2

High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2

Rob Howes, Ph.D.